ERAS - Erasca, Inc. Sales Growth YoY (TTM)

Brandmark of erasca.com (ERAS)

Erasca, Inc. (ERAS) operates in a highly competitive environment, battling pharma behemoths for leadership in developing breakthrough medicines. The trailing 12-month sales growth relative to the previous year illustrates the current pace of development, where 0.00 determines this specific parameter level. Erasca, Inc. (ERAS) leverages its strong scientific authority in developing targeted inhibitors, while the risks associated with a narrow specialization in RAS-mutated tumors are mitigated through strategic partnerships.

Sales Growth YoY (TTM): Erasca Corp (ERAS) for 02/11/2024 - 11/16/2026

Erasca - analytical breakdowns and key metrics (ERAS)

Summary company analytics:ERAS Erasca Oncology
Original product of erasca.com

The operational success of Erasca, Inc. (ERAS) is reflected in the year-over-year sales growth trajectory for the TTM, capturing revenue dynamics over a rolling twelve-month period. For a developer of precision medicines in the testing phase, this indicator measures the pace of commercialization; the absence of stable cash flow makes any positive momentum a signal of emerging from an investment deficit prior to official product approval.

Competitors of Erasca, Inc. (ERAS)

Annual Revenue Growth (Last Twelve Months) BeiGene Corp (ONC)|HALO - Sales Growth YoY (Last Twelve Months)|RVMD: Sales Growth YoY (Last Twelve Months)|AAPG: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth CG Oncology Inc (CGON)|URGN (urogen.com) - Sales Growth YoY (TTM)|BCAX: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Personalis (PSNL)|Revenue Change YoY (Last 12 Months) DCTH|Y-mAbs Therapeutics, Inc. - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Aura Biosciences Inc (AURA)|CADL: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) ARAY (Accuray Inc.)|SLS: Sales Growth YoY (TTM)|ACTU: Revenue Change YoY (Last 12 Months)|CTOR (Citius Oncology Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth tuhurabio.com HURA|Sales Growth YoY (TTM) TARA|FATE: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) WHWK (Aadi Bioscience)|TCRX (TScan) - Trailing Twelve Months Sales Growth|Champions Oncology, Inc. - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) XBiotech Inc XBIT|CVM: Sales Growth YoY (TTM)|OSTX - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Radiopharm Theranostics Limited|Sales Growth YoY (TTM) artivabio.com|Revenue Growth YoY (Last 12 Months) ANL (Adlai Nortye Limited)|Veru - Sales Growth YoY (Last 12 Months)|Tempest Therapeutics, Inc. - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) xiliotx.com (XLO)|Renovaro - Sales Growth YoY (TTM)|Mural Oncology (MURA) - Revenue Growth YoY (Last 12 Months)|KAPA: Sales Growth YoY (TTM)|OKUR - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) CytoMed Therapeutics Limited|CRIS: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) APLM|Sales Growth YoY (TTM) tharimmune.com (THAR)|Advanced Biomed Corp - Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) GNPX|Calidi Biotherapeutics, Inc. - Sales Growth YoY (TTM)|Sunshine Biopharma (SBFM) - Revenue Growth YoY (Last 12 Months)|XBIO: Sales Growth YoY (TTM)|SLRX - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) PPBT|Sales Growth YoY (TTM) American Oncology Network|Sales Growth YoY (Last Twelve Months) BeOne Medicines (BGNE)|CKPT: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) ELEV (Elevation Oncology Inc.)|Sales Growth YoY (TTM) iCAD Corp ICAD|Ikena - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) NTBL (Notable Labs)|VIRX: Sales Growth YoY (TTM)|Trailing Twelve Months Sales Growth MOR (MorphoSys Corp)|Sales Growth YoY (Last Twelve Months) NAYA Biosciences|Sales Growth YoY (TTM) ascentage.com